Kontakt / Dialog 
Neumann-Reichardt-Str. 34
22041 Hamburg
tel.: (040) 672 29 70
fax: (040) 672 49 44
e-mail: dhg@dhg.de
Wir sind Projektpartner des Deutschen Hämophilieregisters und möchten unsere Mitglieder zur Teilnahme am DHR ermuntern. Bitte sprechen Sie dazu auch Ihren Behandler an. Ausführliche Informationen finden Sie hier.
Informationen aus aller Welt
Liebe Mitglieder, unter der Rubrik „International News“ möchten wir Sie über aktuelle Informationen zu den Themen Hämophilie, Blut, Infektionserkrankungen, Sicherheit von Blut und Blutprodukten sowie angrenzende Themen informieren. Die Artikel sind in englischsprachigen Zeitschriften bzw. News Agenturen erschienen. Sie sind in der Regel für Laien geschrieben und daher relativ leicht verständlich.
Hemophilia 2010 World Congress
Registration is now open for the XXIX International Congress of the World Federation of Hemophilia to be held in Buenos Aires, Argentina from July 10-14, 2010. Register before November 20th and take advantage of great savings. Hemophilia 2010 World Congress
WFH statement on H1N1 influenza and vaccination
October 26, 2009 – New vaccines are becoming available for H1N1 influenza as the virus continues to spread around the world. The threat of the H1N1 virus is the same for people with bleeding disorders as for anyone else. For the purposes of vaccination, people with hemophilia and other bleeding disorders should be considered part of the general population. Vaccines are effective tools to prevent infectious diseases and people with bleeding disorders should be vaccinated against the H1N1 virus in accordance with the recommendations of their national health authority. People with hemophilia should be given vaccines only subcutaneously. More information
MSM blood donation policy
The Australian Red Cross prohibits blood donations from men who have sex with men, a policy that has recently been challenged as discriminatory before the Tasmanian Anti-Discrimination Tribunal. The blood agency said lifting the ban would amount to experimenting with the blood supply. The hearing on the matter is still in progress. The Age (Melbourne, Australia)
GSK's HIV drugs linked to heart attacks
Abacavir, an active ingredient in GlaxoSmithKline's HIV treatments Ziagen and Epzicom, is associated with a higher risk of heart attack in older patients, according t o a Danish study. The findings support previous data that prompted GSK to add a warning to Ziagen's prescribing informati on last month. Bloomberg
HIV vaccine
A small section of the HIV protein gp120 is identical in all strains of20the virus, and people make antibodies against it, but in most cases, they're ineffective in fight ing off the infection. However, some people with long-standing HIV infection -- and others with lupus -- appear to make more antibodies and seem to be better protected. Researchers hope that those antibodies hold promise as a microbicide and eventual vaccine. The Washington Post
Aid for patients with liver disease
A North Dakota company has received a $46,000 grant to help it begin producing 30-pound, "high health" specialty pigs that would be raised for use as liver donors. Livers from the pigs would be used by Excorp Medical to help sustain patients with liver disease until they receive a transplant or regrow their own liver tissue. Grand Forks Herald (N.D.)
HIV treatment for young patients
A two-year trial found that Aptivus, a protease inhibitor from Boehringer Ingelheim, was safe and effective in HIV-infected children and adolescents who took other treatments for the condition. The study, which covered 26 sites in the U.S., Europe and Latin America, showed that patient s who received a combination of Aptivus and ritonavir, another HIV drug, had decreased virus levels. Bloomberg (8/4) , Forbes/Thomson Financial
Drug for West Nile virus
Mice infected with the West Nile virus showed a thousandfold drop in virus levels in the brain and a 50% improvement in survival after continuous treatment with AMD3100, researchers reported. The experimental drug allows T cells to get past the blood-brain barrier to fight the virus, which in turn can boost immune-cell trafficking, "ultimately leading to a rapid dampening of inflammation that can have pathologic consequences," the scientists said. Yahoo!/Reuters
HIV drug resistance a growing concern
Increases in international AIDS funds lead to increased treatment of people with HIV in developing countries. But this appears to be increasing HIV drug resistance, particularly to non-nucleoside reverse transcriptase inhibitors, as two drugs in that category are often the standard first-line treatment outside of the West. One point of concern is the lack of programs to monitor the resistance, a problem that will be addressed at the 17th international AIDS conference, which begins20this weekend. Finan cial Times
Blood donations of minorities The American Red Cross today -- National Minority Donor Awareness Day -- is calling for more minority bloo d donors. Minority blood donors play an important role in maintaining the blood supplies in their communities, and some ethnic minorities may have rare blood types that are distinctive to their communities.
Prevalenz of of AIDS
The number of AIDS cases has peaked or stabilized in some nations but has increased in others, according to a report from the Joint United Nations Programme on HIV/AIDS that looked at data from 1 47 countries -- not including the U.S. Data related to the number of U.S. cases is expected to be released by the CDC on Sunday. Although 33 million people worldwide have the virus, less than one-tenth receive antiviral treatment. The Wall Street Journal (free content)
Vaccine-development
Phase I clinical trials for a West Nile virus vaccine developed by Hawaii Biotech -- and a planned test later this year for a Dengue fever vaccine that could see a $2 billion to $5 billion market -- have sparked the interest of Australia-based Avantogen, which sees great promise in the vaccine technology. Avantogen, already a substantial holder of the company's stock, hopes to become a majority shareholder, according to this article. The Herald Sun (Melbourne, Australia)
Treatment of flu virus
Japanese researchers were able to capture a detailed image of the structure of an enzyme that influenza viruses need to reproduce. The finding could lead to the development of novel drugs that target such viruses, including the H5N1 bird flu virus, one of the researchers said. Reuters
HIV drug combos extended lives
Early treatment with drug cocktails known as highly active antiretroviral therapy helped HIV patients live an average of 13 years longer, according to an analysis of 14 studies involving patients in the U.S., Canada and some European countries. Reuters